Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 13 | 13 | 12 | 13 | 12 |
| Accounts receivable | -21 | -37 | 24 | 21 | -59 |
| Other Working Capital | 0 | 127 | 20 | 17 | -287 |
| Other Operating Activity | -711 | -175 | -661 | -614 | -611 |
| Operating Cash Flow | $-719 | $-73 | $-606 | $-562 | $-945 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -7 | -2 | -12 | -13 |
| Purchase Sale Intangibles | -52 | -92 | -59 | -51 | -9 |
| Investing Cash Flow | $-52 | $-99 | $-61 | $-63 | $-21 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 424 | 12 | N/A | N/A | -250 |
| Common Stock Issued | -3 | N/A | -134 | 1 | 3,093 |
| Other Financing Activity | 28 | 0 | 156 | -6 | -127 |
| Financing Cash Flow | $450 | $12 | $23 | $-5 | $2,716 |
| Beginning Cash Position | 580 | 740 | 1,384 | 2,014 | 265 |
| End Cash Position | 258 | 580 | 740 | 1,384 | 2,014 |
| Net Cash Flow | $-321 | $-160 | $-645 | $-630 | $1,750 |
| Free Cash Flow | |||||
| Operating Cash Flow | -719 | -73 | -606 | -562 | -945 |
| Capital Expenditure | -52 | -99 | -61 | -63 | -21 |
| Free Cash Flow | -771 | -172 | -668 | -625 | -966 |